Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gland Pharma Limited Board/Management Information 2021

Jun 29, 2021

59319_rns_2021-06-29_149fcc56-1a2b-4ce3-86d5-4536c104ee6d.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [59 x 48] intentionally omitted <==

==> picture [298 x 20] intentionally omitted <==

June 29, 2021

BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th floor 25[th] floor, Dalal Street Plot no. C-1, Block G, Bandra Kurla Complex Mumbai - 400 001 Bandra (East), Mumbai - 400 051 Scrip Code: 543245 Symbol : GLAND (ISIN : INE068V01023)

Dear Sir/Madam,

Sub: Notice of Board Meeting – Advertisement

In continuation to our intimation dated June 28, 2021, regarding the Board Meeting Notice, please find enclosed copies of the advertisement published in the English and regional (Telugu) newspapers.

This is for your information and records.

Yours truly,

==> picture [217 x 108] intentionally omitted <==

Factory & Regd. Office: Survey No. 143-148, 150 & 151, Near Gandimaisamma 'X' Roads, D.P. Pally, Dundigal, Dundigal-Gandimaisamma Mandal, Medchal-Malkajgiri District, Hyderabad 500043,Telangana, India Tel: +91-40-30510999 Fax; +91-40-30510800, email: [email protected] | www.glandpharma.com CIN: U24239TG1978PLC002276

==> picture [59 x 48] intentionally omitted <==

The Economic Times- June 29, 2021

==> picture [493 x 160] intentionally omitted <==

Financial Express- June 29, 2021

==> picture [499 x 233] intentionally omitted <==

Andhra Prabha- June 29, 2021

==> picture [471 x 199] intentionally omitted <==